| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.808 | 1.398 | 6.975 | 27.095 | 25.948 | 31.435 | 32.022 | 46.955 | 58.792 |
| Total Income - EUR | - | 2.808 | 1.398 | 6.975 | 27.095 | 25.948 | 31.435 | 32.069 | 46.960 | 58.792 |
| Total Expenses - EUR | - | 1.268 | 1.338 | 2.041 | 11.187 | 17.034 | 20.197 | 22.524 | 45.827 | 46.449 |
| Gross Profit/Loss - EUR | - | 1.539 | 60 | 4.935 | 15.907 | 8.914 | 11.238 | 9.545 | 1.133 | 12.344 |
| Net Profit/Loss - EUR | - | 1.455 | 18 | 4.831 | 15.636 | 8.699 | 10.986 | 9.295 | 755 | 10.580 |
| Employees | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sanodia Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 3.398 | 2.880 | 2.375 | 1.885 | 1.414 | 957 | 534 | 4.440 | 8.584 |
| Current Assets | - | 59 | 575 | 6.061 | 22.669 | 31.362 | 42.152 | 32.462 | 19.388 | 21.541 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.201 | 1.973 | 276 |
| Receivables | - | 7 | 97 | 189 | 18.686 | 28.446 | 40.849 | 25.860 | 2.976 | 3.592 |
| Cash | - | 52 | 478 | 5.872 | 3.983 | 2.915 | 1.303 | 5.401 | 14.440 | 17.673 |
| Shareholders Funds | - | 3.018 | 2.985 | 7.761 | 23.247 | 31.505 | 41.846 | 30.993 | 18.469 | 26.765 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 439 | 470 | 675 | 1.307 | 1.271 | 1.263 | 2.003 | 5.359 | 3.360 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanodia Medical S.r.l.